HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
ABBOTT PARK, Ill., April 29, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, odorless ...
San Francisco, Calif. and Torrance, Calif. (June 20, 2002) – A Phase 3 study conducted at multiple research centers in the U.S. under the direction of Ronald Swerdloff, MD, Principal Investigator at ...
DUBLIN, Sept. 8, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized ...
In the authors’ opinion and clinical experience, daily gel application can be disruptive to a patient’s routine. In theory, a higher concentration product should be more convenient because of lower ...
Endo Pharmaceuticals announced that Fortesta Gel - recently approved by the US Food and Drug Administration for the treatment of low testosterone, or ‘Low T’ in adult males - is now available by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results